Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma
作者： Guang-Shun Yang , Hua Wang , Jia-Ji Lin , Jun-Hua Lu , Wen-Ke Cai
DOI:
关键词:
摘要: To investigate the appropriate cutoff point of CA19-9 for prognosis and other potential prognostic factors that may affect survival patients with hilar cholangiocarcinoma (HC) after radical surgery. 168 who had undergone surgery resultant macroscopic curative resection (R0 R1) were discreetly selected analyses. Categorized versions used in univariate model to determine CA19-9. clinicopathologic analyzed influence on by multivariate methods. The strongest predictor among categorized preoperative measures was less than 150 IU/L (P = 0.000). In analysis, tumor size, Bismuth-Corlette classification, portal vein invasion, Lymph node metastasis, margin levels identified as significant factors. multivariable lymph independent our results demonstrated also an factor cholangiocarcinoma, most discriminative proved be at U/ml.
参考文章(36)
S Falkenreck, F Safi, H G Beger, W Schlosser, Prognostic value of CA 19-9 serum course in pancreatic cancer. Hepato-gastroenterology. ,vol. 45, pp. 253- 259 ,(1998)
Victor Ginsburg, Zenon Steplewski, Hilary Koprowski, John L. Magnani, Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin Cancer Research. ,vol. 43, pp. 5489- 5492 ,(1983)
Michael F. Gerhards, Thomas M. van Gulik, Dioniso González González, Erik A.J. Rauws, Dirk J. Gouma, Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World Journal of Surgery. ,vol. 27, pp. 173- 179 ,(2003) , 10.1007/S00268-002-6434-1
B C Del Villano, S Brennan, P Brock, C Bucher, V Liu, M McClure, B Rake, S Space, B Westrick, H Schoemaker, V R Zurawski, Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clinical Chemistry. ,vol. 29, pp. 549- 552 ,(1983) , 10.1093/CLINCHEM/29.3.549
Oliver Micke, Frank Bruns, Rene Kurowski, Eckehard Horst, Alexander F deVries, John W Hausler, Normann Willich, Ulrich Schäfer, Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy. International Journal of Radiation Oncology Biology Physics. ,vol. 57, pp. 90- 97 ,(2003) , 10.1016/S0360-3016(03)00524-8
Attila Nakeeb, Henry A. Pitt, Taylor A. Sohn, JoAnn Coleman, Ross A. Abrams, Steven Piantadosi, Ralph H. Hruban, Keith D. Lillemoe, Charles J. Yeo, John L. Cameron, Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Annals of Surgery. ,vol. 224, pp. 463- 475 ,(1996) , 10.1097/00000658-199610000-00005
Manousos M. Konstadoulakis, Sasan Roayaie, Ilias P. Gomatos, Daniel Labow, Maria-Isabell Fiel, Charles M. Miller, Myron E. Schwartz, Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience The American Journal of Surgery. ,vol. 196, pp. 160- 169 ,(2008) , 10.1016/J.AMJSURG.2007.07.033
S. Jonas, C. Benckert, A. Thelen, E. Lopez-Hänninen, T. Rösch, P. Neuhaus, Radical surgery for hilar cholangiocarcinoma. Ejso. ,vol. 34, pp. 263- 271 ,(2008) , 10.1016/J.EJSO.2007.09.024
A KARACHRISTOS, N SCARMEAS, J HOFFMAN, CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer Journal of Gastrointestinal Surgery. ,vol. 9, pp. 1286- 1292 ,(2005) , 10.1016/J.GASSUR.2005.06.008
M. Ohtsuka, H. Ito, F. Kimura, H. Shimizu, A. Togawa, H. Yoshidome, M. Miyazaki, Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. British Journal of Surgery. ,vol. 89, pp. 1525- 1531 ,(2002) , 10.1046/J.1365-2168.2002.02268.X